GSA Capital Partners LLP bought a new stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 64,779 shares of the real estate investment trust's stock, valued at approximately $1,206,000.
Several other institutional investors have also bought and sold shares of the business. Family Firm Inc. bought a new stake in shares of Sabra Health Care REIT in the 2nd quarter worth about $26,000. Assetmark Inc. increased its stake in Sabra Health Care REIT by 168.4% in the 3rd quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust's stock worth $37,000 after buying an additional 1,231 shares during the period. GAMMA Investing LLC increased its stake in Sabra Health Care REIT by 40.0% in the 2nd quarter. GAMMA Investing LLC now owns 3,682 shares of the real estate investment trust's stock worth $57,000 after buying an additional 1,052 shares during the period. Harbor Capital Advisors Inc. purchased a new position in Sabra Health Care REIT in the 3rd quarter worth about $78,000. Finally, International Assets Investment Management LLC increased its stake in Sabra Health Care REIT by 1,761.0% in the 3rd quarter. International Assets Investment Management LLC now owns 6,104 shares of the real estate investment trust's stock worth $114,000 after buying an additional 5,776 shares during the period. Institutional investors own 99.40% of the company's stock.
Wall Street Analyst Weigh In
A number of research firms have commented on SBRA. Scotiabank raised their target price on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "sector perform" rating in a research report on Friday, October 11th. Truist Financial lifted their target price on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the stock a "buy" rating in a research note on Wednesday, September 4th. Citigroup upgraded shares of Sabra Health Care REIT from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $17.00 to $20.00 in a research note on Friday, September 13th. Finally, Wells Fargo & Company upgraded shares of Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and lifted their target price for the stock from $16.00 to $20.00 in a research note on Tuesday, October 1st. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $18.71.
View Our Latest Report on Sabra Health Care REIT
Sabra Health Care REIT Price Performance
NASDAQ SBRA traded up $0.24 on Friday, hitting $18.18. The company had a trading volume of 2,175,092 shares, compared to its average volume of 2,050,974. The company has a market capitalization of $4.30 billion, a PE ratio of 44.49, a PEG ratio of 2.35 and a beta of 1.25. The company's fifty day moving average price is $18.58 and its 200-day moving average price is $16.51. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.16 and a quick ratio of 4.16. Sabra Health Care REIT, Inc. has a 12-month low of $12.83 and a 12-month high of $20.03.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last issued its earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 EPS for the quarter, missing analysts' consensus estimates of $0.35 by ($0.22). The business had revenue of $178.00 million during the quarter, compared to analyst estimates of $177.19 million. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. During the same quarter last year, the company earned $0.34 earnings per share. As a group, analysts predict that Sabra Health Care REIT, Inc. will post 1.39 earnings per share for the current year.
Sabra Health Care REIT Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 29th. Investors of record on Friday, November 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.60%. The ex-dividend date is Friday, November 15th. Sabra Health Care REIT's payout ratio is currently 292.69%.
About Sabra Health Care REIT
(
Free Report)
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.
Recommended Stories
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.